— Signal history
CRVO alerts
Every time Stock Pulse flagged CRVO in real time — with the full post-mortem behind each alert.
1alert
+58%best run
+58%median peak
-4%worst close
Healthcare · Biotechnology
CervoMed Inc.
CervoMed is a ~$20M biotech with an FDA-aligned Phase 3 path for neflamapimod in dementia with Lewy bodies, but no partner and, until this filing, not much cash.
Cap~$23M / float: 6.3M
Day volume200.7M (~478x avg)
Prev close$2.48 → day high $7.45 (+200%)
52w range$2.13–$13.13
Snapshot from the Jun 16, 2026 post-mortem.
